Exact Mass: 305.1522

Exact Mass Matches: 305.1522

Found 80 metabolites which its exact mass value is equals to given mass value 305.1522, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

BUPROFEZIN

Pesticide5_Buprofezin_C16H23N3OS_(2Z)-2-(tert-Butylimino)-3-(1-methylethyl)-5-phenyl-1,3,5-thiadiazinan-4-one

C16H23N3OS (305.1562)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10057; ORIGINAL_PRECURSOR_SCAN_NO 10056 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10079; ORIGINAL_PRECURSOR_SCAN_NO 10078 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10113; ORIGINAL_PRECURSOR_SCAN_NO 10111 ORIGINAL_ACQUISITION_NO 10127; CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10127; ORIGINAL_PRECURSOR_SCAN_NO 10126 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10097; ORIGINAL_PRECURSOR_SCAN_NO 10096 CONFIDENCE standard compound; INTERNAL_ID 402; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10129; ORIGINAL_PRECURSOR_SCAN_NO 10128

   

6-Oxolividamine

6-Oxolividamine

C12H23N3O6 (305.1587)


   

4-Oxolividamine

4-Oxolividamine; 3-Deoxy-4-oxoparomamine

C12H23N3O6 (305.1587)


An aminoglycoside that is 4alpha,6alpha-diaminocyclohexane-1beta,2alpha,3beta-triol in which the pro-R hydroxy group has been converted into its 2-amino-2,3-dideoxy-alpha-D-erythro-hexopyranosid-4-ulose derivative.

   

Syndesine

2-amino-6-[(E)-(5-amino-5-carboxy-2-hydroxypentylidene)amino]-5-hydroxyhexanoic acid

C12H23N3O6 (305.1587)


Syndesine is found in animal foods. Syndesine is an intramolecular crosslink of collagen. An intramolecular crosslink of collagen. Syndesine is found in animal foods.

   

Methionyl-Arginine

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-5-carbamimidamidopentanoic acid

C11H23N5O3S (305.1522)


Methionyl-Arginine is a dipeptide composed of methionine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Arginylmethionine

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanoic acid

C11H23N5O3S (305.1522)


Arginylmethionine is a dipeptide composed of arginine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

3-[(4-carboxy-3-hydroxy-4-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an (2S,3R)-3-hydroxy-2-methylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyhexanedioylcarnitine

3-[(5-carboxy-3-hydroxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


3-hydroxyhexanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyhexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyhexanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyhexanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Ethyl-2-hydroxybutanedioylcarnitine

3-[(3-carboxy-3-ethyl-3-hydroxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO7 (305.1474)


2-Ethyl-2-hydroxybutanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethyl-2-hydroxybutanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethyl-2-hydroxybutanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Ethyl-2-hydroxybutanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-((N-(1-(1H-Imidazol-4-yl)-2-propyl)imino)phenylmethyl)phenol

2-({[1-(1H-imidazol-5-yl)propan-2-yl]imino}(phenyl)methyl)phenol

C19H19N3O (305.1528)


   

Applaud

2-Tert-butylimino-3-isopropyl-5-phenyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazin-4-one

C16H23N3OS (305.1562)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   
   
   

Decarbomethoxy naucl echine

Decarbomethoxy naucl echine

C19H19N3O (305.1528)


   

Goshuyuamide I

Goshuyuamide I

C19H19N3O (305.1528)


   

18-demethyl-19-hydroxy-Na-demethyl-Nb-methyl-suaveoline|Na, 18-Didemethyl-19-hydroxy-Nb-methylsuavelien

18-demethyl-19-hydroxy-Na-demethyl-Nb-methyl-suaveoline|Na, 18-Didemethyl-19-hydroxy-Nb-methylsuavelien

C19H19N3O (305.1528)


   

Beta-Naucleonine|Naucleonine

Beta-Naucleonine|Naucleonine

C19H19N3O (305.1528)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Arg-met

2-[2-amino-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanoic acid

C11H23N5O3S (305.1522)


A dipeptide formed from L-arginine and L-methionine residues.

   

Met-arg

2-(2-amino-5-carbamimidamidopentanamido)-4-(methylsulfanyl)butanoic acid

C11H23N5O3S (305.1522)


A dipeptide formed from L-methionine and L-arginine residues.

   

Syndesine

2-amino-6-[(E)-(5-amino-5-carboxy-2-hydroxypentylidene)amino]-5-hydroxyhexanoic acid

C12H23N3O6 (305.1587)


   

tert-butyl 2-[hydroxy(dimethyl)silyl]-5-methylindole-1-carboxylate

tert-butyl 2-[hydroxy(dimethyl)silyl]-5-methylindole-1-carboxylate

C16H23NO3Si (305.1447)


   

1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-benz oimidazol-2-one

1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-benz oimidazol-2-one

C19H19N3O (305.1528)


   

Trimorpholinophosphine oxide

Trimorpholinophosphine oxide

C12H24N3O4P (305.1504)


   

(3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID

(3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYL)BORONIC ACID

C15H20BNO5 (305.1434)


   

Orphenadrine hydrochloride

Orphenadrine hydrochloride

C18H24ClNO (305.1546)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AB - Ethers chemically close to antihistamines D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents

   

Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, conjugate acid(1:1)

Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-, conjugate acid(1:1)

C19H19N3O (305.1528)


   

3-(4-tert-butylphenyl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

3-(4-tert-butylphenyl)-4-(3-methoxypropyl)-1H-1,2,4-triazole-5-thione

C16H23N3OS (305.1562)


   

H-Ala-Ala-Ala-OMe acetate salt

H-Ala-Ala-Ala-OMe acetate salt

C12H23N3O6 (305.1587)


   

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzonitrile

C19H20BNO2 (305.1587)


   

Bifemelane hydrochloride

Bifemelane hydrochloride

C18H24ClNO (305.1546)


   

6-((1S)-1-Aminoethyl)-N-(3,4,5-trimethoxyphenyl)-1,2,4-triazin-3-amine

6-((1S)-1-Aminoethyl)-N-(3,4,5-trimethoxyphenyl)-1,2,4-triazin-3-amine

C14H19N5O3 (305.1488)


   

[6-ethoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[6-ethoxy-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C15H20BNO5 (305.1434)


   

2-[(p-methyl-alpha-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride

2-[(p-methyl-alpha-phenylbenzyl)oxy]ethyl(dimethyl)ammonium chloride

C18H24ClNO (305.1546)


   
   

N,N-dimethyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride

N,N-dimethyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride

C18H24ClNO (305.1546)


   

tert-Butyl 3-morpholin-3-yl-propionate oxalate

tert-Butyl 3-morpholin-3-yl-propionate oxalate

C13H23NO7 (305.1474)


   

(4-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid

(4-(3-(Ethoxycarbonyl)piperidine-1-carbonyl)phenyl)boronic acid

C15H20BNO5 (305.1434)


   

Benzyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate

Benzyl 4-((trimethylsilyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate

C16H23NO3Si (305.1447)


   

2-Acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

2-Acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid

C15H20BNO5 (305.1434)


   

1-[4-(aminomethyl)phenyl]-N,N-dimethylpiperidin-4-amine,dihydrochloride

1-[4-(aminomethyl)phenyl]-N,N-dimethylpiperidin-4-amine,dihydrochloride

C14H25Cl2N3 (305.1425)


   

Methionyl-Arginine

Methionyl-Arginine

C11H23N5O3S (305.1522)


   
   

3-Hydroxyhexanedioylcarnitine

3-Hydroxyhexanedioylcarnitine

C13H23NO7 (305.1474)


   

2-Ethyl-2-hydroxybutanedioylcarnitine

2-Ethyl-2-hydroxybutanedioylcarnitine

C13H23NO7 (305.1474)


   

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

(2S,3R)-3-hydroxy-2-methylpentanedioylcarnitine

C13H23NO7 (305.1474)


   

Disipal

Disipal

C18H24ClNO (305.1546)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents

   

Alnert

Alnert

C18H24ClNO (305.1546)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

1-(2,6-Dimethylphenyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]thiourea

1-(2,6-Dimethylphenyl)-3-[3-(2-oxopyrrolidin-1-yl)propyl]thiourea

C16H23N3OS (305.1562)


   

N-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide

N-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide

C16H23N3OS (305.1562)


   

N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide

N-(1-adamantyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide

C16H23N3OS (305.1562)


   
   
   
   
   
   
   
   
   
   
   
   
   

(3R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

(3R)-8-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

C14H25O7- (305.16)


   

(3R,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

(3R,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxyoctanoate

C14H25O7- (305.16)


   

Arginyl-methionine

Arginyl-methionine

C11H23N5O3S (305.1522)


   

n-methyl-2-{1h,3h,4h,9h-pyrido[3,4-b]indole-2-carbonyl}aniline

n-methyl-2-{1h,3h,4h,9h-pyrido[3,4-b]indole-2-carbonyl}aniline

C19H19N3O (305.1528)